Physician profile

Robert Daniel Davis

Podiatrist · Bridgeport, CT

NPI 1801975537

$427,308.48

in general payments reported to CMS, 2019-2025

44 companies · $130K in 2025

The $130K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$123,282.50
Consulting Fee$36,210.00
Travel and Lodging$32,409.62
Food and Beverage$9,608.61

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Organogenesis INC. $167,767.00 2019-2025 Puraply Wound Matrix, Affinity, Novachor
Smith+Nephew, INC. $129,701.26 2019-2025 Grafix, Stravix, Oasis
Osiris Therapeutics INC. $75,289.68 2019
Horizon Therapeutics Plc $37,098.13 2019-2023 Krystexxa
Ortho Dermatologics, A Division of Bausch Health US, LLC $9,129.36 2019-2025 Jublia
Convatec INC. $2,102.06 2019-2025
Mimedx Group, INC. $1,283.55 2024
Stryker Corporation $888.49 2019-2025 Dart-Fire, Actishield, Augment Injectable
Paratek Pharmaceuticals, INC. $669.82 2021-2025 Nuzyra
Melinta Therapeutics, LLC $323.28 2019-2022
Triad Life Sciences INC. $257.33 2022
Kci USA, INC. $250.48 2019-2023 Tegaderm, Promogran Prisma, 3m Coban
Kerecis Limited $210.13 2022-2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide
Acera Surgical, INC. $207.92 2019-2024 Restrata Wound Matrix
Amgen INC. $196.02 2024-2025 Krystexxa
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Grt US Holding, INC. $191.18 2020-2022
Bioventus LLC $181.30 2019-2025 Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Sonicone Clinic
Ibsa Pharma INC. $178.53 2020-2024 Tirosint, Licart, Tirosint
Solventum Corporation $176.37 2024-2025 Promogran Prisma, V.A.C. Veraflo, V.A.C.Ulta
Next Science LLC $156.53 2021-2023 Xperience, Blastx, Surgx
Baudax Bio INC. $112.17 2020-2022
Nuo Therapeutics $105.93 2023
Treace Medical Concepts, INC. $96.31 2024-2025
Advanced Oxygen Therapy INC. $87.19 2024 Topical Oxygen Chamber For Extremities
Orthofix Medical, INC. $83.09 2019-2024 Physio-Stim, Accelstim
Merck Sharp & Dohme LLC $69.01 2019
Trice Medical, INC. $48.60 2024
Misonix INC $46.01 2021
Nabriva Therapeutics, Plc $41.79 2020-2022
Sebela Pharmaceuticals INC. $36.29 2021-2022
Bone Support INC. $35.90 2024 Ceramentbone Void Filler, Cerament G
Kowa Pharmaceuticals America, INC. $35.65 2022
Medtronic, INC. $30.67 2023 Venaseal
Reprise Biomedical, INC. $28.18 2025 Miro3d
Hydrofera LLC $22.84 2025 Hydrofera Blue Ready - Border
Abbvie INC. $22.31 2024
Chiesi USA, INC. $20.98 2025 Filsuvez
Averitas Pharma INC. $20.20 2024 Qutenza
Sanara Medtech INC. $19.80 2025 Celleraterx
Ethicon US, LLC $19.70 2023 Surgiflo Hemostatic Matrix
Acell, INC. $19.06 2020
Alfasigma USA, INC. $17.82 2020
Integra Lifesciences Corporation $17.01 2024 Integra, Integra Dermal Regeneration Template, Primatrix
Zimmer Biomet Holdings, INC. $13.55 2019

Drugs and devices associated with these payments

Grafix $78KPuraply Wound Matrix $68KStravix $55KAffinity $51KOasis $47KNovachor $40KNushield $32KApligraf $30KNa $27KGrafix Pl $17KPuraply Antimicrobial $16KGrafix Xc $16KStravix Mesh $6,654Stravix Pl $3,774Puraply $3,000Innovamatrix Ac $1,923Versajet $1,681Collagenase Santyl $634Kerecis Omega3 Marigen $465Nuzyra $409Kerecis Omega3 Surgiclose $305Pico $270Dart-Fire $268Krystexxa $213Renasys Touch $204Promogran Prisma $177Regranex $167Actishield $160Renasys Go V2 Home $160Evos $131V.A.C. Veraflo $126Kerecis Omega3 Graftguide $112Tirosint $109Cygnus Dual $108Activ.A.C. $95.33Iodosorb Ointment 40g USA $91.32Puraply Franchise $89.99Topical Oxygen Chamber For Extremities $87.19Licart $86.55Activ.A.C. Ion Progress $81.42Evos Mini $80.69Panta 2 $80.693m Coban $77.50Tegaderm $72.53V.A.C.Ulta $68.82Xperience $68.40Surgx $68.40Blastx $68.40V.A.C. Dermatac $53.91Exogen Ultrasound Bone Healing System $53.43Memofix Super Elastic Nitinol Staple System $51.35Integra $51.03Prevena $50.69Accelstim $49.77Physio-Stim $49.77Augment Injectable $47.97Spatial Frame $46.48Aquacel Ag+ $40.91Cerament G $35.90Ceramentbone Void Filler $35.90Variax $34.85Venaseal $30.67Miro3d $28.18Silvercel $26.92Fibracol Plus $26.92Restrata Wound Matrix $26.84Lapiplasty System $26.82Allowrap $23.43Hydrofera Blue Ready - Border $22.84Dalvance $22.31Teflaro $22.31Avycaz $22.31Filsuvez $20.98Qutenza $20.20Celleraterx $19.80Jublia $19.71Surgiflo Hemostatic Matrix $19.70Promogran $19.68Primatrix $17.01Integra Dermal Regeneration Template $17.01Sonicone Clinic $14.78Aquacel Ag+ Extra $13.25Peri-Loc $10.33

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Daniel Davis

$427,308.48

in general payments reported 2019-2025

Years
2019-2025
Top company
Organogenesis INC.
Context
The $130K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).

https://glasscript.com/doctor/217421/robert-daniel-davis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.